Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 75 | 125 | 200 | 189 | 393 |
| Gross Profit | 75 | 125 | 200 | 189 | 393 |
| Operating Expenses | 802 | 911 | 1,053 | 1,045 | 1,069 |
| Operating Income | -727 | -786 | -853 | -856 | -676 |
| Pre-tax Income | -727 | -786 | -853 | -856 | -676 |
| Net Income Continuous | -727 | -786 | -853 | -856 | -676 |
| Net Income | $-727 | $-786 | $-853 | $-856 | $-676 |
| EPS Basic Total Ops | -0.60 | -0.56 | -0.32 | -0.28 | -0.24 |
| EPS Basic Continuous Ops | -0.58 | -0.57 | -0.30 | -0.30 | -0.24 |
| EPS Diluted Total Ops | -0.60 | -0.56 | -0.32 | -0.28 | -0.24 |
| EPS Diluted Continuous Ops | -0.58 | -0.57 | -0.30 | -0.30 | -0.24 |
| EBITDA(a) | $-724 | $-784 | $-850 | $-854 | $-647 |